During the forecast period 2023-2033, the Chloangiocarcinoma (CCA) Therapeutics market is expected to grow at a value of 2% CAGR, according to Future Market Insights. By the year 2033, the global market for Chloangiocarcinoma (CCA) Therapeutics is expected to rise up to a market valuation of US$ 975.20 Million. Growth of the market can be …
Author Archives: Editor AN
Dystrophic Epidermolysis Bullosa Management Market to reach US$ 787.8 Million by 2033, Antibiotics to Constitute 32% of all Treatments | FMI Study
According to Future Market Insights, global dystrophic epidermolysis bullosa management is expected to grow at a CAGR of 5.7% between 2023 and 2033, reaching US$ 787.8 Million in 2033. With a rise in the prevalence of dystrophic epidermolysis bullosa, coupled with increased research for treating this condition, global dystrophic epidermolysis bullosa treatment is expected to …
Adoption of New Assays and Launch of Combination Drugs Will Propel Growth of Complicated Urinary Tract Infections Treatment Market | FMI Study
The global Complicated Urinary Tract Infections treatment market size is expected to surpass an impressive valuation of USD 9.2 billion in 2023 and is projected to reach USD 16.1 billion by 2033, trailing a CAGR of 5.76% An advanced platform called biosensors are used for the diagnosis of complicated urinary tract infection which will drive …
The Global Encephalitis Treatment Market Is Expected to Register Growth at 5.4% CAGR through 2033 | FMI Study
The global encephalitis treatment market is currently valued at US$ 20.14 Billion in 2023 and is anticipated to expand at a CAGR of 5.4%. Owing to the technological advances in healthcare the market is likely to propel to US$ 34.08 Billion by 2033. The major factor attributing to the growth of the market is the high mortality and …
From 2023 through 2033, Cancer Biopsy sales to expand at a CAGR of over 18%, Reveals Future Market Insights
The Cancer Biopsy market revenues were estimated at US$ 22.2 Bn in 2022 and is anticipated to grow at a CAGR of 18% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 131.4 Bn. The increasing elderly populace, along with …
Global Hyperpigmentation Treatment market to exhibit a CAGR of 7.4% until 2033, reaching US$ 11.84 billion: FMI Study
The global hyperpigmentation treatment market is predicted to exceed an impressive valuation with a compound annual growth rate (CAGR) of 7.4% projected from 2023 to 2033. Skin hyperpigmentation results from a slight decrease in melanin synthesis. Laser treatment, cosmeceuticals, and chemical peels can all be used to treat hyperpigmentation disorders. The global hyperpigmentation market is …
Global Hidradenitis Suppurative (HS) Treatment Market to reach US$ 1,240.9 million by 2033, Biologics to comprise over 64% of all Treatments | FMI Report
The global hidradenitis suppurativa (HS) treatment market is expected to surpass an impressive valuation of US$ 763.6 million in 2023 and is projected to reach US$ 1,240.9 million by 2033, growing at a CAGR of 4.97%. Hidradenitis suppurativa market is currently having vast pipeline therapies targeting interleukins, including (i.e., IL-17, IL-1), anti-TNF, JAKi, and anti-complement …
From 2022 through 2032, Cardiovascular Ultrasound Revenue to expand at a CAGR of over 7%, States Future Market Insights
The Cardiovascular Ultrasound market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as …
Precocious Puberty Treatment Market to reach US$ 3,650.66 million by 2033, registering a 7.8% CAGR | FMI Study
The global precocious puberty treatment market is anticipated to attain an impressive valuation of US$ 1,716.43 million in 2023 and is projected to reach US$ 3,650.66 million by 2033, trailing a CAGR of 7.8% during the forecast period. The focus of key industry players on getting product approval from regulatory authorities such as United States …
The Tapioca Market is predicted to be worth US$ 4.1 Billion through 2033, Read full report by FMI
In 2023, the market share of tapioca was estimated to be worth US$ 4.1 Bn. By 2033, it was estimated to be worth US$ 6.3 Bn. This is expected to further boost the market share of tapioca and generate a CAGR of 4.4%. Agroecological adaptability and producing higher yields at a lower investment, cassava plants are helping …